Alembic Pharmaceuticals has reported results for first quarter ended June 30, 2018.
The company has reported over 2-fold jump in its net profit at Rs 113.98 crore for the quarter under review as compared to net profit of Rs 50.67 crore for the same quarter in the previous year. Total income of the company increased by 37.48% at Rs 811.58 crore for Q1FY19 as compared Rs 590.34 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a rise of 35.70% in its net profit at Rs 90.47 crore for the quarter under review as compared to Rs 66.67 crore for the same quarter in the previous year. Total consolidated income of the company increased by 33.05% at Rs 862.63 crore for Q1FY19 as compared Rs 648.36 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1462.50 |
Dr. Reddys Lab | 5784.50 |
Cipla | 1451.25 |
Zydus Lifesciences | 1001.15 |
Lupin | 1587.90 |
View more.. |